Since the global call to action in 2017, the Hub has been steadfast in fulfilling its mandate to enhance co-operation and collaboration in and strengthen AMR research and development, reducing duplicative efforts and efficient allocation of resources. Find out more about what impact activities are having across sectors in our new Impact Snapshot for 2024.
The Global AMR R&D Hub (the Hub) played an important role in supporting the development of the policy case for Canada’s Antibiotic Access Pilot Project. Over a two-year period, the Hub engaged in multiple consultations with Canada, providing valuable insights into the investment landscape for AMR R&D, among other topics. Additionally, Canada’s AMR Task Force leveraged the Hub’s resources, such as the Dynamic Dashboard, its reports and network, during the policy formulation process. The partnership between the Hub and Canada’s AMR Task Force supported the policy case and rationale for a pilot project aimed at securing access to new antibiotics for Canadians.
